Three findings from the report:
1. Of the 2,235 investment deals across AI startups last year, 367 were in healthcare, for a total of $4 billion.
2. The surge in funding for AI startups in healthcare and beyond was led by a swath of “mega-rounds” of financing reaching at least $100 million, as well as a new crop of “unicorn” startups valued at $1 billion or more. In healthcare, Babylon Health achieved both designations: It reached unicorn status after raising $550 million in August for its AI-enabled medical chatbot.
3. 2019 also saw a record number of AI startups making exits, either through mergers and acquisitions or initial public offerings. Of the 231 M&A deals and 10 IPOs across all industries, healthcare startups were responsible for 17 M&A deals and two IPOs.
View the full report here.
More articles on AI:
Vanderbilt researchers receive $2.7M to use AI for suicide prediction
Medtronic CEO: $1.6B Mazor Robotics acquisition is ‘beginning to pay off’
IBM proposes guidelines to battle AI bias
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
